The Genadyne XLR8 Wound Vacuum System is an advanced NPWT system that promotes wound healing. Portable and lightweight, it is designed to be used in all environments.
• Caregiver can lock unit to ensure trouble-free accurate operation
• Light weight and carry bag helps speed up patient mobilization
• Canister tubing comes pre-assembled for user friendliness
• A small and light pump for freedom of movement
• Built-in Li-ion battery fully recharges in 3 hours
• Large, easy-to-read interface for easy setup
• Whisper quiet operation
The Genadyne XLR8 Wound Vacuum System is indicated for use in patients who would benefit from negative pressure wound therapy particularly as the device may promote wound healing by the removal of excess exudates, infectious material and tissue debris.
Genadyne XLR8 Therapy is contraindicated for patients with malignancy in the wound, untreated osteomyelitis, non-enteric and unexplored fistulas, necrotic tissue with eschar present (NOTE: After debridement of necrotic tissue and complete removal of eschar, Genadyne XLR8 Therapy may be used.)
Do not place dressing directly in contact with exposed blood vessels, anastomotic sites, organs, or nerves.
Precautions should be taken for patients who are or may be receiving anticoagulant therapy, suffering from difficult hemostasis, untreated for malnutrition and non-compliant or combative.
To reduce the risk of transmission of blood-borne pathogens, apply standard precautions for infection control with all patients, per institutional protocol, regardless of their diagnosis or presumed infection status. In addition to gloves, use gown and goggles if exposure to body fluid is likely.
Continuous, rather than intermittent, Genadyne XLR8 Therapy is recommended over unstable structures, such as an unstable chest wall or non-intact fascia, in order to help minimize movement and stabilize the wound bed. Continuous therapy is also generally recommended for patients at increased risk of bleeding, highly exudating wounds, fresh flaps and grafts, and wounds with acute enteric fistulae.
The size and weight of the patient should be considered when prescribing Genadyne XLR8 Therapy. Infants, children, certain small adults and elderly patients should be closely monitored for fluid loss and dehydration. Also, patients with highly exudating wounds or large wounds in relation to the patient size and weight should be closely monitored, as they may have a risk of excessive fluid loss and dehydration. When monitoring fluid output, consider the volume of fluid in both the tubing and canister.
In the event a patient experiences autonomic hyperreflexia (sudden elevation in blood pressure or heart rate in response to stimulation of the sympathetic nervous system), discontinue Genadyne XLR8 Therapy to help minimize sensory stimulation and seek immediate medical assistance.
To minimize the risk of bradycardia, the Genadyne XLR8 Therapy dressing must not be placed in proximity to the vagus nerve.
Wounds with enteric fistulas require special precautions to optimize Genadyne XLR8 Therapy. In certain circumstances, the Genadyne XLR8 Therapy may help to promote healing in wounds with an enteric fistula. When the physician orders the Genadyne XLR8 Therapy, it is recommended that support from an expert clinician is sought. Genadyne XLR8 Therapy is not recommended or designed for fistula effluent management or containment, but as an aid to wound healing. Genadyne XLR8 Therapy is not recommended if enteric fistula effluent management or containment is the sole goal of this therapy.
Consider use of a skin preparation product to protect periwound skin. Do not allow wound filler to overlap onto intact skin. Protect fragile/friable periwound skin with additional hydrocolloid or other transparent film. Multiple layers of the transparent film dressing may decrease the moisture vapor transmission rate, which may increase the risk of maceration. If any signs of irritation or sensitivity to the film dressing, wound filler or tubing assembly appear, discontinue use and consult a physician. To avoid trauma to the periwound skin, do not pull or stretch the transparent film over the wound filler dressing during film application. Extra caution should be used for patients with neuropathic etiologies or circulatory compromise.
Avoid use of circumferential dressings except in the presence of anasarca or excessively weeping extremities, where a circumferential film technique may be necessary to establish and maintain a seal. Consider using multiple small pieces of transparent film rather than one continuous piece to minimize the risk of decreased distal circulation. Extreme care should be taken not to stretch or pull the film when securing it, but let it attach loosely and stabilize edges with an elastic wrap if necessary. When using circumferential film techniques, it is crucial to systematically and recurrently palpate distal pulses and assess distal circulatory status. If circulatory compromise is suspected, discontinue therapy, remove dressing and contact a physician.
|Accommodates large wounds||●|
|Accommodates small wounds||●|
|Antimicrobial interface available|
|Portable (under 1lb)||●|
|Single-use – 10 days|
|Single-use – 15 days|
|Single-use – 30 days|
|Single-use – 7 days|
|Usable on closed wounds|
|Usable on open wounds|
|Variable pressure setting|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available|
Moderate/Highly Exudating Wounds
Protect the periwound skin with the XLR8 Drape, ensuring the film is as close to the edge of the wound as possible and not covering any open area of the wound. Cut the GreenFoam the size and shape of the wound. Avoid cutting the GreenFoam over the wound.
Place the GreenFoam into the wound cavity ensuring it comes into contact with all the wound margins and sites about the level of the wound. Ensure the GreenFoam is not packed tightly into the wound. Cover the GreenFoam with the XLR8 Drape. Avoid compressing the GreenFoam with the XLR8 Drape, or stretching the XLR8 Drape. Cut a hole in the covering film roughly the size of a quarter. Remove the paper back off the PortPad dressing and apply it over the hole that was cut in the XLR8 Drape. Attach the PortPad dressing luer lock to the canister luer lock end. Turn the unit on, ensure there are not any leaks.
Service Life (est.): Unlimited (Brushless motor)
Minmum Vacuum: 50mmHg
Maximum Vacuum: 230mmHg
Suction capacity: ~4 liters per minute
Power: 19 VDC, 1.58A 30W (Min), 20 VDC (Max)
Battery Type: Li-Ion rechargeable batteries
Recharge Time: ~ 3 hours
Safety: EN55011 Class B, UL/cUL 6601-1, TUV/GS EN60601-1, CE Mark (LVD)
Operating Conditions: 18°C to 34°C, 65°F to 94°F
Relative Humidity: 10% to 95%
STORAGE AND SHIPPING CONDITIONS
Ambient Temperature: 0°F to 110°F, -18°C to 43°C
Relative Humidity: 10% to 95 %
IEC 60601-1-2 CAN/CSA C22.2 No. 601.1
Genadyne Biotechnologies manufactures pressure relieving mattress systems and advanced NPWT systems, while offering a wide variety of wound care solutions through extensive research and development.